https://wikimd.com/index.php?action=history&feed=atom&title=RanimustineRanimustine - Revision history2026-04-06T00:40:48ZRevision history for this page on the wikiMediaWiki 1.44.2https://wikimd.com/index.php?title=Ranimustine&diff=5640509&oldid=prevPrab: CSV import2024-04-21T13:41:29Z<p>CSV import</p>
<p><b>New page</b></p><div>[[File:Ranimustine_(Haworth).svg|Ranimustine (Haworth)|thumb]] '''Ranimustine''' is a [[chemotherapy]] drug used in the treatment of certain types of [[cancer]], including [[brain cancer]] and [[leukemia]]. It belongs to a class of chemotherapy drugs known as [[nitrosoureas]], which work by damaging the [[DNA]] of [[cancer cells]], thereby inhibiting their growth and multiplication. Ranimustine is often used in combination with other chemotherapy drugs to enhance its therapeutic effects.<br />
<br />
== Mechanism of Action ==<br />
Ranimustine causes cross-linking of DNA strands, leading to DNA damage and ultimately the death of cancer cells. This drug is cell-cycle non-specific, meaning it can kill cancer cells at any phase of their growth cycle. Its ability to cross the [[blood-brain barrier]] makes it particularly useful in treating cancers of the central nervous system.<br />
<br />
== Uses ==<br />
Ranimustine is primarily used in the treatment of:<br />
* [[Brain tumors]], including [[glioma]]s and [[astrocytoma]]s<br />
* [[Leukemia]], particularly [[acute lymphoblastic leukemia]] (ALL) and [[acute myeloid leukemia]] (AML)<br />
* Other cancers as part of combination chemotherapy regimens<br />
<br />
== Side Effects ==<br />
Like all chemotherapy drugs, ranimustine can cause a range of side effects due to its effect on both cancerous and healthy cells. Common side effects include:<br />
* [[Nausea]] and [[vomiting]]<br />
* [[Bone marrow suppression]], leading to [[anemia]], [[leukopenia]] (low white blood cell count), and [[thrombocytopenia]] (low platelet count)<br />
* Increased risk of [[infection]]<br />
* [[Hair loss]]<br />
* [[Mucositis]] (inflammation of the lining of the digestive tract)<br />
<br />
Severe side effects may include [[pulmonary fibrosis]] (scarring of the lung tissue) and secondary malignancies due to its DNA-damaging effects.<br />
<br />
== Administration ==<br />
Ranimustine is administered intravenously. The dosage and schedule depend on the type of cancer being treated, the patient's overall health, and how well they respond to therapy.<br />
<br />
== Research and Development ==<br />
Research on ranimustine continues to explore its efficacy and safety profile in various cancers, as well as its potential in combination therapies. Studies are also investigating the mechanisms behind its side effects, with the aim of improving patient outcomes and quality of life during treatment.<br />
<br />
== Conclusion ==<br />
Ranimustine remains an important drug in the arsenal against certain cancers, particularly those affecting the brain and blood. Ongoing research and clinical trials will further define its role in cancer therapy and potentially expand its use in oncology.<br />
<br />
[[Category:Chemotherapy agents]]<br />
[[Category:Nitrosoureas]]<br />
{{medicine-stub}}</div>Prab